These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

547 related items for PubMed ID: 19914732

  • 1. Targeted therapies for non-small cell lung cancer.
    Dempke WC, Suto T, Reck M.
    Lung Cancer; 2010 Mar; 67(3):257-74. PubMed ID: 19914732
    [Abstract] [Full Text] [Related]

  • 2. Combining targeted therapies and drugs with multiple targets in the treatment of NSCLC.
    Maione P, Gridelli C, Troiani T, Ciardiello F.
    Oncologist; 2006 Mar; 11(3):274-84. PubMed ID: 16549812
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Targeting novel and established therapies for non-small cell lung cancer.
    Spicer J, Chowdhury S, Harper P.
    Cancer Lett; 2007 May 18; 250(1):9-16. PubMed ID: 17030089
    [Abstract] [Full Text] [Related]

  • 5. Targeted therapies for non-small-cell lung cancer: biology, rationale, and preclinical results from a radiation oncology perspective.
    Raben D, Helfrich B, Bunn PA.
    Int J Radiat Oncol Biol Phys; 2004 May 18; 59(2 Suppl):27-38. PubMed ID: 15142632
    [Abstract] [Full Text] [Related]

  • 6. The emerging role of vascular endothelial growth factor receptor tyrosine kinase inhibitors.
    Langer CJ, Natale RB.
    Semin Oncol; 2005 Dec 18; 32(6 Suppl 10):S23-9. PubMed ID: 16459176
    [Abstract] [Full Text] [Related]

  • 7. Shortcomings of current therapies for non-small-cell lung cancer: unmet medical needs.
    Burris HA.
    Oncogene; 2009 Aug 18; 28 Suppl 1():S4-13. PubMed ID: 19680296
    [Abstract] [Full Text] [Related]

  • 8. The role of anti-epidermal growth factor receptor and anti-vascular endothelial growth factor therapies in the treatment of non-small-cell lung cancer.
    Langer C, Soria JC.
    Clin Lung Cancer; 2010 Mar 01; 11(2):82-90. PubMed ID: 20199973
    [Abstract] [Full Text] [Related]

  • 9. Epidermal growth factor receptor inhibitors in the treatment of non-small cell lung cancer.
    Agelaki S, Georgoulias V.
    Expert Opin Emerg Drugs; 2005 Nov 01; 10(4):855-74. PubMed ID: 16262567
    [Abstract] [Full Text] [Related]

  • 10. Integrating new targeted agents into the treatment of non-small-cell lung cancer.
    Thatcher N.
    Lung Cancer; 2006 Dec 01; 54 Suppl 2():S25-31. PubMed ID: 17056150
    [Abstract] [Full Text] [Related]

  • 11. Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderly.
    Gridelli C, Massarelli E, Maione P, Rossi A, Herbst RS, Onn A, Ciardiello F.
    Cancer; 2004 Oct 15; 101(8):1733-44. PubMed ID: 15386339
    [Abstract] [Full Text] [Related]

  • 12. Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Introduction.
    Bunn PA, Thatcher N.
    Oncologist; 2008 Oct 15; 13 Suppl 1():1-4. PubMed ID: 18263768
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of the unresectable non small cell lung carcinoma].
    Spásová I.
    Cas Lek Cesk; 2005 Oct 15; 144(9):602-12; discussion 612-3. PubMed ID: 16193938
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic strategy for treatment of metastatic non-small cell lung cancer.
    Berhoune M, Banu E, Scotte F, Prognon P, Oudard S, Bonan B.
    Ann Pharmacother; 2008 Nov 15; 42(11):1640-52. PubMed ID: 18957625
    [Abstract] [Full Text] [Related]

  • 15. Combined inhibition of the VEGFR and EGFR signaling pathways in the treatment of NSCLC.
    Pennell NA, Lynch TJ.
    Oncologist; 2009 Apr 15; 14(4):399-411. PubMed ID: 19357226
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The potential of antiangiogenic therapy in non-small cell lung cancer.
    Giaccone G.
    Clin Cancer Res; 2007 Apr 01; 13(7):1961-70. PubMed ID: 17404076
    [Abstract] [Full Text] [Related]

  • 18. The current status of targeted therapy for non-small cell lung cancer.
    Francis H, Solomon B.
    Intern Med J; 2010 Sep 01; 40(9):611-8. PubMed ID: 20002849
    [Abstract] [Full Text] [Related]

  • 19. Beyond antiepidermal growth factor receptors and antiangiogenesis strategies for nonsmall cell lung cancer: exploring a new frontier.
    Sangha R, Lara PN, Mack PC, Gandara DR.
    Curr Opin Oncol; 2009 Mar 01; 21(2):116-23. PubMed ID: 19532012
    [Abstract] [Full Text] [Related]

  • 20. New antiangiogenetic agents and non-small cell lung cancer.
    Gridelli C, Rossi A, Maione P.
    Crit Rev Oncol Hematol; 2006 Oct 01; 60(1):76-86. PubMed ID: 16843002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.